Enovis Corporation
NYSE:ENOVMedical - Devices
+$0.73 today
- Market cap
- $1.56B
- Beta
- 1.49
- P/E (TTM)
- -1.1
- EPS (TTM)
- -$20.02
Volume 0.88M
Average 0.99M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$217.29M
FY 2025 · Annual
+91.4% YoYInvesting Cash Flow
-$179.37M
FY 2025 · Annual
Financing Cash Flow
-$52.40M
FY 2025 · Annual
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 76.28M | (11.76M) | (33.26M) | (824.82M) | (1.18B) |
| Depreciation & Amortization | 262.92M | 219.71M | 217.1M | 284.8M | 294.38M |
| Deferred Income Tax | (22.19M) | 6.32M | (27.41M) | (10.02M) | (2.23M) |
| Stock-Based Compensation | 35.35M | 38.96M | 34.07M | 29.66M | 32.92M |
| Change in Working Capital | (17.1M) | (220.49M) | (27.27M) | (13.93M) | 15.47M |
| Accounts Receivables | (110.99M) | (45.19M) | (16.32M) | (57.05M) | (10.75M) |
| Inventory | (129.97M) | (118.79M) | (24.74M) | 39.07M | (11.98M) |
| Accounts Payables | 178.47M | (11.84M) | (6.64M) | 13.98M | (1.14M) |
| Other Working Capital | 45.38M | (44.67M) | 20.42M | (9.93M) | 39.34M |
| Other Non-Cash Items | 20.84M | (88.59M) | (28.24M) | 647.81M | 1.06B |
| Operating Cash Flow | 356.1M | (55.86M) | 134.99M | 113.5M | 217.29M |
| Capital Expenditures | (104.24M) | (105.45M) | (122.22M) | (180.71M) | (197.38M) |
| Acquisitions (Net) | (223.27M) | (73.68M) | (152.82M) | (769.91M) | 16.4M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 7.03M | 2.75M | 32.57M | (4.85M) | 1.6M |
| Investing Cash Flow | (320.48M) | (176.39M) | (242.47M) | (955.47M) | (179.37M) |
| Debt Repayment | (150.41M) | (1.59B) | 217.2M | 859.23M | (43.6M) |
| Common Stock Issued | 745.18M | 5.81M | 1.78M | 1.87M | 1.32M |
| Common Stock Repurchased | 0 | 0 | 0 | (4.77M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (9.87M) | 1.12B | (91.17M) | (9.51M) | (10.12M) |
| Financing Cash Flow | 584.91M | (465.13M) | 127.8M | 846.82M | (52.4M) |
| Effect of Forex Changes | (2.23M) | 2.3M | 219K | (1.52M) | 2.7M |
| Net Change in Cash | 618.3M | (695.08M) | 20.54M | 3.34M | (11.78M) |
| Free Cash Flow | 251.86M | (161.31M) | 12.77M | (67.21M) | 19.92M |
Free Cash Flow
Net Income to FCF bridge
FY2025
Analysis
FY2025 free cash flow is $19.9M. FCF conversion is -1.7% of net income. Operating cash flow was $217.3M, with capex of -$197.4M. The largest bridge item is Other Non-Cash at $1.1B.
Competitors
Peer companies in the same sector
ITT Inc.
NYSE:ITT
Market cap
$18.84B
IDEX Corporation
NYSE:IEX
Market cap
$17.45B
Watts Water Technologies, Inc.
NYSE:WTS
Market cap
$12.03B
Donaldson Company, Inc.
NYSE:DCI
Market cap
$10.04B
The Middleby Corporation
NASDAQ:MIDD
Market cap
$6.11B
EnPro Industries, Inc.
NYSE:NPO
Market cap
$5.79B
Franklin Electric Co., Inc.
NASDAQ:FELE
Market cap
$4.34B
Kadant Inc.
NYSE:KAI
Market cap
$3.47B
Enerpac Tool Group Corp.
NYSE:EPAC
Market cap
$2.02B
The Gorman-Rupp Company
NYSE:GRC
Market cap
$1.84B
Helios Technologies, Inc.
NYSE:HLIO
Market cap
$1.53B
Graham Corporation
NYSE:GHM
Market cap
$979.18M
Luxfer Holdings PLC
NYSE:LXFR
Market cap
$464.01M
Omega Flex, Inc.
NASDAQ:OFLX
Market cap
$236.61M
Hurco Companies, Inc.
NASDAQ:HURC
Market cap
$131.92M
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 10, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 |
Does ENOV generate free cash flow?
Enovis Corporation (ENOV) generated $19.92M of free cash flow in fiscal 2025.
How much operating cash flow does ENOV produce?
Operating cash flow was $217.29M, before capital expenditures of $197.38M.
Continue the stock analysis
Jump to another research area for this company.